Senior Bioengineer, Vienna

The role

The Senior Bioengineer will design and build next-generation organoid models, culture formats, and custom hardware. This role involves advancing organoid architecture, developing co-culture systems, and implementing bench-level automation.

What you will do

• Design and test improved organoid formats including scaffold composition and perfusion
• Develop methods for introducing immune populations within tissue scaffolds
• Design, prototype and iterate custom culture hardware
• Characterize engineering changes by tying them to biological readouts
• Determine organoid positioning and coupling methods in multi-organoid systems
• Build co-culture systems linking immune organoids to other tissue types
• Design formats with the constraints of automated systems in mind
• Implement bench-level automation for routine culture steps
• Write and implement SOPs and hardware documentation
• Work with US team on platform development and share expertise

Required qualifications

• PhD in bioengineering, biomedical engineering, biophysics, biotechnology or a related field, with 5+ years of hands-on experience beyond the PhD; or an MSc with 8+ years of industry experience
• Demonstrated experience building 3D tissue or organoid culture systems, including hydrogels, scaffolds, ECM selection and matrix characterization
• Hands-on experience designing and fabricating custom culture hardware
• CAD, 3D printing, soft lithography, laser cutting or comparable prototyping methods
• Solid cell culture skills and the ability to work with primary human cells
• Broad immunological background across innate and adaptive immunity
• Practical experience with liquid handlers and associated lab hardware, for example Hamilton, Tecan or Lynx platforms, alongside plate readers and automated incubators
• Strong record of documenting designs and experiments and communicating results
• Track record of driving a technical project independently, from concept through prototype to validated system
• Ability to work at the boundary between engineering and biology

Nice to have

• Experience with scalable organ-on-chip, microfluidic or perfusion systems
• Experience with iPSC culture or differentiation
• Familiarity with Python or R
• Familiarity with imaging and computational analysis tools

About the company

parallel-bio is building a human-first drug discovery platform powered by organoids and AI. The company has raised approximately $30M from investors including AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator.